Clinical trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell…
NCT00408005 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00408005 |
|---|---|
| Title | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma |
| Official title | Intensified Methotrexate, Nelarabine (Compound 506U78) and Augmented BFM Therapy for Children and Young Adults With Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma |
| Intervention type | Drug, Other, Radiation |
| Interventions | Asparaginase, Cyclophosphamide, Cytarabine, Daunorubicin Hydrochloride, Dexamethasone, Doxorubicin Hydrochloride, Laboratory Biomarker Analysis, Leucovorin Calcium, Mercaptopurine, Methotrexate and 6 more |
| Enrollment | 1,895 |
| Start date | Jan 30, 2007 |
| Primary completion | Sep 30, 2017 |
| Completion | Mar 31, 2025 |
| First posted | Dec 5, 2006 |
| Last update posted | Apr 20, 2025 |
| Countries | Australia, Canada, New Zealand, Switzerland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: